Tools
ToolsSteverding, Dietmar (2013) Proteases of Trypanosoma brucei. In: Trypanosomatid Diseases: Molecular Routes to Drug Discovery. Wiley, Weinheim, pp. 365-382.
Full text not available from this repository. (Request a copy)Abstract
Human African trypanosomiasis (HAT) or sleeping sickness is a parasitic infection caused by the protozoan Trypanosoma brucei. The disease occurs in sub-Saharan Africa where it is a major cause of morbidity and mortality in man. Combinations of toxicity and poor efficacy of current anti-sleeping sickness drugs means that new, effective, and better tolerated chemotherapies are needed for the treatment of human African trypanosomiasis. Proteases play a key role in the life cycle of T. brucei and in the pathogenesis of sleeping sickness. In vitro and in vivo studies over the last decades have shown that proteases are valid targets for the development of new drugs against T. brucei. Here, the major proteases of T. brucei and their cellular roles and potential as drug targets will be reviewed.
| Item Type: | Book Section |
|---|---|
| Uncontrolled Keywords: | sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology |
| Depositing User: | Pure Connector |
| Date Deposited: | 04 Feb 2015 12:48 |
| Last Modified: | 30 Sep 2021 17:11 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/52018 |
| DOI: |
Actions (login required)
 |
View Item |